Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nolan

Showing results (261-270 of 381) with videos related to

Pageof 39
Sort By:
Breast Cancer Research and Treatment|October 12, 2018
Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancerLutfi H Alfarsi, Rokaya Elansari, Michael S Toss, et al.
Glia|February 18, 2004
Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood-brain barrier in the apparent absence of direct astrocytic contactColin L Willis, Christopher C Nolan, Sharon N Reith, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|February 1, 2018
Optimal Intereye Difference Thresholds in Retinal Nerve Fiber Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple SclerosisRachel C Nolan, Steven L Galetta, Teresa C Frohman, et al.
Synapse (New York, N.Y.)|June 15, 2013
Fos expression in response to dopamine D3-preferring phenylpiperazine drugs given with and without cocaineBrian C Nolan, Shinban Liu, Lindsey R Hammerslag, et al.
The Journal of Pharmacy and Pharmacology|August 1, 1990
AHR-15010--a novel anti-arthritic agentJ C Nolan, D A Walsh, Y Lo, et al.
Journal of Biomolecular Screening|July 18, 2013
High-throughput screening normalized to biological response: application to antiviral drug discoveryDhara A Patel, Anand C Patel, William C Nolan, et al.
Breast Cancer Research : BCR|March 24, 2018
The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumoursRokaya El Ansari, Madeleine L Craze, Islam Miligy, et al.
Psychopharmacology|February 26, 2021
The acute effects of alcohol on state rumination in the laboratoryO Merve Mollaahmetoglu, Edward Palmer, Emily Maschauer, et al.
Agents and Actions|August 1, 1990
AHR-10037, a non-steroidal anti-inflammatory compound of low gastric toxicityL F Sancilio, J C Nolan, L E Wagner, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1990
AHR-14310C: a potent, long-acting, nonsedating H1-antihistamine that prevents antigen-induced mucus formation in sensitive ratsJ C Nolan, M H Foxwell, L L Whitman, et al.
Pageof 39

Showing results (261-270 of 381) with videos related to

Sort By:
Pageof 39
Breast Cancer Research and Treatment|October 12, 2018
Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancerLutfi H Alfarsi, Rokaya Elansari, Michael S Toss, et al.
Glia|February 18, 2004
Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood-brain barrier in the apparent absence of direct astrocytic contactColin L Willis, Christopher C Nolan, Sharon N Reith, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|February 1, 2018
Optimal Intereye Difference Thresholds in Retinal Nerve Fiber Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple SclerosisRachel C Nolan, Steven L Galetta, Teresa C Frohman, et al.
Synapse (New York, N.Y.)|June 15, 2013
Fos expression in response to dopamine D3-preferring phenylpiperazine drugs given with and without cocaineBrian C Nolan, Shinban Liu, Lindsey R Hammerslag, et al.
The Journal of Pharmacy and Pharmacology|August 1, 1990
AHR-15010--a novel anti-arthritic agentJ C Nolan, D A Walsh, Y Lo, et al.
Journal of Biomolecular Screening|July 18, 2013
High-throughput screening normalized to biological response: application to antiviral drug discoveryDhara A Patel, Anand C Patel, William C Nolan, et al.
Breast Cancer Research : BCR|March 24, 2018
The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumoursRokaya El Ansari, Madeleine L Craze, Islam Miligy, et al.
Psychopharmacology|February 26, 2021
The acute effects of alcohol on state rumination in the laboratoryO Merve Mollaahmetoglu, Edward Palmer, Emily Maschauer, et al.
Agents and Actions|August 1, 1990
AHR-10037, a non-steroidal anti-inflammatory compound of low gastric toxicityL F Sancilio, J C Nolan, L E Wagner, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1990
AHR-14310C: a potent, long-acting, nonsedating H1-antihistamine that prevents antigen-induced mucus formation in sensitive ratsJ C Nolan, M H Foxwell, L L Whitman, et al.
Pageof 39